1 INTRODUCTION OF THE GLOBAL CANCER BIOPSY MARKET

1.1 Market Definition

1.2 Market Segmentation

1.3 Research Timelines

1.4 Assumptions

1.5 Limitations
2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

2.1 Data Mining

2.2 Data Triangulation

2.3 Bottom-Up Approach

2.4 Top-Down Approach

2.5 Research Flow

2.6 Key Insights from Industry Experts

2.7 Data Sources
3 EXECUTIVE SUMMARY

3.1 Market Overview

3.2 Ecology Mapping

3.3 Absolute Market Opportunity

3.4 Market Attractiveness

3.5 Global Cancer Biopsy Market Geographical Analysis (CAGR %)

3.6 Global Cancer Biopsy Market, By Type (USD Million)

3.7 Global Cancer Biopsy Market, By Application (USD Million)

3.8 Future Market Opportunities

3.9 Global Market Split

3.10 Product Life Line
4 GLOBAL CANCER BIOPSY MARKET OUTLOOK

4.1 Global Cancer Biopsy Evolution

4.2 Drivers

4.2.1 Driver 1

4.2.2 Driver 2

4.3 Restraints

4.3.1 Restraint 1

4.3.2 Restraint 2

4.4 Opportunities

4.4.1 Opportunity 1

4.4.2 Opportunity 2

4.5 Porters Five Force Model

4.6 Value Chain Analysis

4.7 Pricing Analysis

4.8 Macroeconomic Analysis
5 GLOBAL CANCER BIOPSY MARKET, BY TYPE

5.1 Overview

5.2 Tissue Biopsies

5.3 Liquid Biopsies
6 GLOBAL CANCER BIOPSY MARKET, BY PRODUCT

6.1 Overview

6.2 Kits & Consumables

6.3 Instruments
7 GLOBAL CANCER BIOPSY MARKET, BY GEOGRAPHY

7.1 Overview

7.2 North America 

7.2.1 U.S.

7.2.2 Canada

7.2.3 Mexico

7.3 Europe 

7.3.1 Germany

7.3.2 U.K.

7.3.3 France

7.3.4 Italy

7.3.5 Spain

7.3.6 Rest of Europe

7.4 Asia Pacific 

7.4.1 China

7.4.2 Japan

7.4.3 India

7.4.4 Rest of Asia Pacific

7.5 Latin America 

7.5.1 Brazil

7.5.2 Argentina

7.5.3 Rest of Latin America

7.6 Middle-East and Africa

7.6.1 UAE

7.6.2 Saudi Arabia

7.6.3 South Africa

7.6.4 Rest of Middle-East and Africa
8 GLOBAL CANCER BIOPSY MARKET COMPETITIVE LANDSCAPE

8.1 Overview

8.2 Company Market Ranking

8.3 Key Developments

8.4 Company Regional Footprint

8.5 Company Industry Footprint

8.6 ACE Matrix
9 COMPANY PROFILES
9.1 Illumina, Inc.

9.1.1 Company Overview

9.1.2 Company Insights

9.1.3 Product Benchmarking

9.1.4 Key Development
9.2 ANGLE Plc

9.2.1 Company Overview

9.2.2 Company Insights

9.2.3 Product Benchmarking

9.2.4 Key Development
9.3 BD (Becton, Dickinson and Company)

9.3.1 Company Overview

9.3.2 Company Insights

9.3.3 Product Benchmarking

9.3.4 Key Development
9.4 Myriad Genetics

9.4.1 Company Overview

9.4.2 Company Insights

9.4.3 Product Benchmarking

9.4.4 Key Development
9.5 Hologic, Inc.

9.5.1 Company Overview

9.5.2 Company Insights

9.5.3 Product Benchmarking

9.5.4 Key Development
9.6 Biocept, Inc.

9.6.1 Company Overview

9.6.2 Company Insights

9.6.3 Product Benchmarking

9.6.4 Key Development
9.7 Thermo Fisher Scientific, Inc.

9.7.1 Company Overview

9.7.2 Company Insights

9.7.3 Product Benchmarking

9.7.4 Key Development
9.8 Danaher

9.8.1 Company Overview

9.8.2 Company Insights

9.8.3 Product Benchmarking

9.8.4 Key Development
9.9 F. Hoffmann-La Roche Ltd.

9.9.1 Company Overview

9.9.2 Company Insights

9.9.3 Product Benchmarking

9.9.4 Key Development
9.10 Lucence Diagnostics Pte. Ltd.

9.10.1 Company Overview

9.10.2 Company Insights

9.10.3 Product Benchmarking

9.10.4 Key Development
10 VERIFIED MARKET INTELLIGENCE

10.1 About Verified Market Intelligence

10.2 Dynamic Data Visualization
LIST OF TABLES

TABLE 1 "Global Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 2 Global Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 3 Global Cancer Biopsy Market, By Geography, 2023 – 2030 (USD Billion)

TABLE 4 North America Cancer Biopsy Market, By Country, 2023 – 2030 (USD Billion)

TABLE 5 "North America Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 6 North America Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 7 "US Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 8 US Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 9 "Canada Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 10 Canada Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 11 "Mexico Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 12 Mexico Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 13 Europe Cancer Biopsy Market, By Country, 2023 – 2030 (USD Billion)

TABLE 14 "Europe Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 15 Europe Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 16 "Germany Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 17 Germany Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 18 "UK Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 19 UK Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 20 "France Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 21 France Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 22 "Rest of Europe Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 23 Rest of Europe Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 24 Asia-Pacific Cancer Biopsy Market, By Country, 2023 – 2030 (USD Billion)

TABLE 25 "Asia-Pacific Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 26 Asia-Pacific Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 27 "China Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 28 China Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 29 "Japan Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 30 Japan Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 31 "India Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 32 India Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 33 "Rest of Asia-Pacific Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 34 Rest of Asia-Pacific Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 35 RoW Cancer Biopsy Market, By Country, 2023 – 2030 (USD Billion)

TABLE 36 "RoW Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 37 RoW Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 38 "Middle East and Africa Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 39 Middle East and Africa Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 40 "Latin America Cancer Biopsy Market, By Type, 2023 – 2030 (USD Billion)"

TABLE 41 Latin America Cancer Biopsy Market, By Application, 2023 – 2030 (USD Billion)

TABLE 42 Qiagen N.V.: Product Benchmarking

TABLE 43 Qiagen N.V.: Key Development

TABLE 44 Illumina, Inc.: Product Benchmarking

TABLE 45 Illumina, Inc.: Key Development

TABLE 46 ANGLE Plc: Product Benchmarking

TABLE 47 ANGLE Plc: Key Development

TABLE 48 ANGLE Plc: Product Benchmarking

TABLE 49 ANGLE Plc: Key Development

TABLE 50 BD (Becton, Dickinson and Company): Product Benchmarking

TABLE 51 BD (Becton, Dickinson and Company): Key Development

TABLE 52 Myriad Genetics: Product Benchmarking

TABLE 53 Myriad Genetics: Key Development

TABLE 54 Hologic, Inc.: Product Benchmarking

TABLE 55 Hologic, Inc.: Key Development

TABLE 56 Biocept, Inc.: Product Benchmarking

TABLE 57 Biocept, Inc.: Key Development

TABLE 58 Thermo Fisher Scientific, Inc.: Product Benchmarking

TABLE 59 Thermo Fisher Scientific, Inc.: Key Development

TABLE 60 Danaher: Product Benchmarking

TABLE 61 Danaher: Key Development

TABLE 62 F. Hoffmann-La Roche Ltd.: Product Benchmarking

TABLE 63 F. Hoffmann-La Roche Ltd.: Key Development

TABLE 64 Lucence Diagnostics Pte. Ltd.: Key Development

TABLE 65 GRAIL, Inc.: Key Development

TABLE 66 Guardant Health: Key Development
LIST OF FIGURES

FIGURE 1 Global Cancer Biopsy Market Segmentation

FIGURE 2 Research Timelines

FIGURE 3 Data Triangulation

FIGURE 4 Market Research Flow

FIGURE 5 Data Sources

FIGURE 6 Global Cancer Biopsy Market Overview

FIGURE 7 Global Cancer Biopsy Market Geographical Analysis, 2020-2028

FIGURE 8 "Global Cancer Biopsy Market, By Type

(USD Million)"

FIGURE 9 Global Cancer Biopsy Market, By Application (USD Million)

FIGURE 10 Future Market Opportunities

FIGURE 11 Porters Five Force Model

FIGURE 12 COVID-19 Analysis

FIGURE 13 Global Cancer Biopsy Market Geographical Analysis, 2019-2028

FIGURE 14 "Global Cancer Biopsy Market, By Type

(USD Million)"

FIGURE 15 Global Cancer Biopsy Market, By Application (USD Million)

FIGURE 16 North America Snapshot

FIGURE 17 North America Cancer Biopsy Market Share, By Country, 2020

FIGURE 18 Europe Snapshot

FIGURE 19 Europe Cancer Biopsy Market Share, By Country, 2020

FIGURE 20 Asia-Pacific Snapshot

FIGURE 21 Asia-Pacific Cancer Biopsy Market Share, By Country, 2020

FIGURE 22 RoW Snapshot

FIGURE 23 RoW Cancer Biopsy Market Share, By Country, 2020

FIGURE 24 Key Strategic Developments

FIGURE 25 Qiagen N.V. Company Insight

FIGURE 26 SWOT Analysis: Qiagen N.V.

FIGURE 27 Illumina, Inc. Company Insight

FIGURE 28 SWOT Analysis: Illumina, Inc.

FIGURE 29 ANGLE Plc Company Insight

FIGURE 30 SWOT Analysis: ANGLE Plc

FIGURE 31 BD (Becton, Dickinson and Company) Company Insight

FIGURE 32 Myriad Genetics Company Insight

FIGURE 33 Hologic, Inc. Company Insight

FIGURE 34 Biocept, Inc. Company Insight

FIGURE 35 Thermo Fisher Scientific, Inc. Company Insight

FIGURE 36 Danaher Company Insight

FIGURE 37 F. Hoffmann-La Roche Ltd. Company Insight

FIGURE 38 Lucence Diagnostics Pte. Ltd. Company Insight

FIGURE 39 GRAIL, Inc. Company Insight

FIGURE 40 Guardant Health Company Insight

The research starts with the extensive procurement process of data/information and statistics from company annual reports, government websites, statistics agencies, and paid databases. This information creates a base for the study. The information also helps to define the scope and to narrow down the area for study for the market. This raw information is processed and analyzed to extract crisp data points which currently affect or are likely to affect the industry during the forecast period. After analyzing the information, a proprietary statistical tool is used for market estimation and forecast, which generates the quantitative figures of the market/sub-segments in the current scenario as well as for the forecast period. 

After estimating the markets and estimates, the numbers are verified with industry participants and key opinion leaders. The wide network of industry participants add value to the research and verify the numbers and estimates provided in the study. At the last stage of the research process, a final report is prepared, which is then published on different websites as well as distributed through various channels. The below figure contains the different stages of the research process to produce the report.

1.1 DATA MINING
Data mining is an extensive part of our research process. It involves the procurement of market data and related information from different verified and credible sources. This step helps to obtain raw information about the industry and their Drivetrain, the monetary process for different end uses, the pool of market participants, and the nature of the industry and scope of the study. The data mining stage comprises both primary and secondary sources of information.
1.2 SECONDARY RESEARCH
In the secondary research process, various sources are used to identify and gather industry trends and information for the research process. We at TRI have access to some of the most diversified and extensive paid databases, which give us the most accurate data/information on markets Customers, and pricing. Mentioned below is a detailed list of sources that have been used for this study. Please note that this list is not limited to the names as mentioned; we also access other data sources depending on the need.
1.3 PRIMARY RESEARCH
In the primary research process, in-depth primary interviews are conducted with the CXOs to understand the market share, customer base, pricing strategies, channel partners, and other necessary information. Besides, in-depth primary interviews are conducted with the CXOs of vendors, channel partners, and others to validate the supply-side information. In addition, various key industry participants from both the supply and demand side are interviewed to obtain qualitative and quantitative information on the market. In-depth interviews with key primary respondents, including industry professionals, subject matter experts (Corporates), industry consultants, and C-Component executives of major companies, are conducted to obtain critical qualitative and quantitative information pertaining to the market, as well as to assess the prospects for market growth during the forecast period. Detailed information on these primary respondents is mentioned below. 
1.4 FORCASTING TECHNIQUES
We at Markstats Research Insights Private Limited follow an extensive process for arriving at market estimations, which involves the use of multiple forecasting techniques as mentioned below.